Skip to main content
letter
. 2014 Nov 11;29(3):741–744. doi: 10.1038/leu.2014.306

Figure 1.

Figure 1

Kaplan–Meier survival curves of 84 myelofibrosis patients treated with single agent momelotinib stratified by CALR/ASXL1 mutation status. Survival was calculated from the time of study entry.